 [15] 
  The Prothonotary found there were reasonable grounds for Apotex to assert that Roche is subject to control by SPIL on the basis that SPIL: 
 
 
 
 a) is the owner of the '671 patent, 
 
 
 
 b) was a party to the prohibition proceeding, and 
 
 
 
 c) is a company related to Roche. 
